What we're reading, January 4, 2016: health insurers offering free doctor's visits for some plans; some consumers find paying the Affordable Care Act penalty cheaper than buying insurance; and clinicians and patients are increasingly worried about opioid dangers.
In more than a dozen markets across the countries, health insurers will be offering plans that include free doctor’s visits—no copays, coinsurance or expensive deductible. According to Kaiser Health News, the move is a response to reports that despite signing up for health coverage under the Affordable Care Act (ACA), many Americans have found high copays and deductibles make actually using their new health insurance too expensive.
Although 2016 is the year that penalties under the ACA’s individual mandate reach a tipping point so that purchasing health insurance is more affordable than paying the fine, this is not the case for all Americans. While the number of new enrollees is 29% higher than the same time last year, there are plenty of holdouts remaining, reported The New York Times. These individuals earn too much to qualify for federal subsidies and would prefer to hope they stay healthy throughout the year.
Clinicians and patients are increasingly concerned about the dangers of opioids. About two-thirds of health professionals believe patients are frequently taking more than prescribed and 69% said they are prescribing fewer opioids than in the past. In addition, almost half (46%) of patients agreed these drugs are being used in ways other than they had been prescribed, reported Medscape. However, only 23% of consumers report disposing of unused opioids, while 42% store these unused pills for future use, WebMD found.
Unmet Needs Remain in Secondary AML Following Treatment With HMAs
January 18th 2025The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated with hypomethylating agents (HMAs) for myeloid neoplasms such as myelodysplastic syndromes.
Read More
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More